Tuesday, May 19, 2020

ChromaCode Snags $10M In Series C

Carlsbad-based ChromaCode, which is developing molecular testing equipment, announced today that it has raised $10M in a Series C extension round. The funding came from Adjuvant Capital. As part of the funding, ChromaCode said that it will add Adjuvant Capital's Managing Partner, Jenny Yip, to its board. The company has now raised $38M in the Series C round. ChromaCode said the new funds will go to support global expansion and continued development of ChromaCode's high-definition PCR platform. The company's other venture backers include Northpond Ventures, New Enterprise Associates (NEA), Domain Associates, Windham Ventures, Okapi Ventures, Moore Venture Partners and the California Institute of Technology. More information »

---